KCM
CELG

Knoll Capital Management’s Celgene Corp CELG Stock Holding History

Knoll Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-55,850
Closed -$225K – 18
2013
Q3 		$225K Hold
55,850
– – 0.12% 9
2013
Q2 		$204K Buy
+55,850
New +$3.36M 0.14% 10

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Knoll Capital Management's CELG Position: Q4 2013 in Review

Knoll Capital Management sold out of Celgene Corp (CELG) in Q4 2013, closing a stake of 55,850 shares — an estimated $225K sold.

Knoll Capital Management first reported a position in CELG in Q2 2013 and held it in 2 quarters. The position peaked at $225K in Q3 2013. 983 funds tracked by Wall St. Rank hold CELG as of Q4 2013.

  • Knoll Capital Management reported no remaining Celgene Corp position as of Q4 2013 after selling out during the quarter.
  • Knoll Capital Management sold 55,850 Celgene Corp shares in Q4 2013, an estimated $225K.
  • Knoll Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 2 quarters.
  • Knoll Capital Management's Celgene Corp position peaked at $225K in Q3 2013.
  • 983 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2013.

Based on Knoll Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.